These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 23328511

  • 1. [Safety and short-term efficacy of renal sympathetic denervation in the treatment of resistant hypertension].
    Jiang XJ, Liang T, Dong H, Peng M, Ma WJ, Guan T, Zhang HM, Bian J, Xu B, Gao RL.
    Zhonghua Yi Xue Za Zhi; 2012 Dec 11; 92(46):3265-8. PubMed ID: 23328511
    [Abstract] [Full Text] [Related]

  • 2. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 3. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 12; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 4. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 12; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 5. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 6. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension.
    Damascelli B, Patelli G, Tichá V, Della Rocca F, Lattuada S, Sala C, Albertoni A, D'Alessio A, Funaro A, Scotti L.
    J Vasc Interv Radiol; 2013 May 09; 24(5):632-9. PubMed ID: 23622036
    [Abstract] [Full Text] [Related]

  • 7. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238
    [Abstract] [Full Text] [Related]

  • 8. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H, de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Gaspar A, Sousa H, Canha Gomes A, Andrade MJ, Carvalho MS, Campante Teles R, Raposo L, Mesquita Gabriel H, Pereira Machado F, Mendes M.
    Rev Port Cardiol; 2014 Apr 30; 33(4):197-204. PubMed ID: 24472425
    [Abstract] [Full Text] [Related]

  • 9. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H, Jiang X, Liang T, Zou Y, Guan T, Peng M, Song L, Zhang H, Wu H, Xu B, Yang Y, Gao R.
    J Invasive Cardiol; 2014 Jul 30; 26(7):322-7. PubMed ID: 24993989
    [Abstract] [Full Text] [Related]

  • 10. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 11. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 01; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 12. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG.
    Int J Cardiol; 2015 Dec 15; 201():345-50. PubMed ID: 26301677
    [Abstract] [Full Text] [Related]

  • 13. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul 15; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 14. Feasibility of catheter ablation renal denervation in "mild" resistant hypertension.
    Chen S, Kiuchi MG, Acou WJ, Derndorfer M, Wang J, Li R, Kollias G, Martinek M, Kiuchi T, Pürerfellner H, Liu S.
    J Clin Hypertens (Greenwich); 2017 Apr 15; 19(4):361-368. PubMed ID: 28266770
    [Abstract] [Full Text] [Related]

  • 15. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.
    Eur Heart J; 2013 Jul 15; 34(28):2114-21. PubMed ID: 23786861
    [Abstract] [Full Text] [Related]

  • 16. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J.
    Hypertension; 2016 Feb 15; 67(2):397-403. PubMed ID: 26693818
    [Abstract] [Full Text] [Related]

  • 17. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
    Bartuś K, Sadowski J, Kapelak B, Zajdel W, Godlewski J, Bartuś S, Bochenek M, Bartuś M, Żmudka K, Sobotka PA.
    Kardiol Pol; 2013 Feb 15; 71(2):152-8. PubMed ID: 23575708
    [Abstract] [Full Text] [Related]

  • 18. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A, Schmieder R, Lell M, Janka R, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2016 Mar 15; 39(3):426-32. PubMed ID: 26253780
    [Abstract] [Full Text] [Related]

  • 19. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
    Vink EE, Verloop WL, Siddiqi L, van Schelven LJ, Liam Oey P, Blankestijn PJ.
    Int J Cardiol; 2014 Sep 15; 176(1):8-12. PubMed ID: 25027168
    [Abstract] [Full Text] [Related]

  • 20. Improvement of albuminuria after renal denervation.
    Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE.
    Int J Cardiol; 2014 May 01; 173(2):311-5. PubMed ID: 24681017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.